Literature DB >> 23752773

Diabetes: individualized HbA(1c) targets in elderly patients with T2DM.

Linda Koch.   

Abstract

Entities:  

Year:  2013        PMID： 23752773     DOI： 10.1038/nrendo.2013.114

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  1 in total

1.  Individualised treatment targets for elderly patients with type 2 diabetes using vildagliptin add-on or lone therapy (INTERVAL): a 24 week, randomised, double-blind, placebo-controlled study.

Authors:  W David Strain; Valentina Lukashevich; Wolfgang Kothny; Marie-José Hoellinger; Päivi Maria Paldánius
Journal:  Lancet       Date:  2013-05-23       Impact factor: 79.321
  1 in total
  1 in total

1.  Effects of dose escalating liraglutide from 1.2 to 1.8 mg in clinical practice: a case-control study.

Authors:  M Rigato; A Avogaro; G P Fadini
Journal:  J Endocrinol Invest       Date:  2015-09-02       Impact factor: 4.256
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.